Hsbc Holdings PLC Ngm Biopharmaceuticals Inc Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $30,618 - $42,973	2,432 Added 23.55%	12,757 $167,000
Q2 2022 Aug 11, 2022	BUY	$10.58 - $17.5 $109,238 - $180,687	10,325 New	10,325 $132,000
Q2 2021 Aug 13, 2021	SELL	$15.06 - $30.03 $135,479 - $270,149	-8,996 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$24.99 - $31.93 $57,626 - $73,630	-2,306 Reduced 20.4%	8,996 $261,000
Q4 2020 Feb 12, 2021	SELL	$16.21 - $31.44 $65,569 - $127,174	-4,045 Reduced 26.36%	11,302 $342,000
Q3 2020 Nov 12, 2020	BUY	$15.59 - $19.97 $71,573 - $91,682	4,591 Added 42.68%	15,347 $248,000
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $3,850 - $7,511	385 Added 3.71%	10,756 $135,000
Q4 2019 Feb 14, 2020	SELL	$9.97 - $20.28 $158,174 - $321,742	-15,865 Reduced 60.47%	10,371 $190,000
Q3 2019 Nov 14, 2019	BUY	$13.09 - $18.19 $343,429 - $477,232	26,236 New	26,236 $363,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.